Related Experiment Video
Updated: Jun 17, 2026
Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
Published on: November 20, 2015
Prematurity prevention: the role of acute tocolysis
Yair J Blumenfeld1, Deirdre J Lyell
1Division of Maternal-Fetal Medicine, Department of Obstetrics & Gynecology, Stanford University, 300 Pasteur Drive, Room HH333, Stanford, California 94305, USA.
Insights
Acute tocolysis can delay preterm birth, improving neonatal outcomes. Oral nifedipine shows equal efficacy to magnesium sulfate with fewer maternal side effects, supporting its use as a first-line treatment.
Area of Science:
- Obstetrics and Gynecology
- Neonatal Medicine
- Pharmacology
Background:
- Preterm birth rates in the US are alarmingly high and increasing.
- Acute tocolysis aims to delay birth by 48 hours, facilitating antenatal steroid administration and improving neonatal outcomes.
- Medical providers need current information on tocolytic agents, including their efficacy, indications, contraindications, and adverse effects.
Purpose of the Study:
- To review common acute tocolytic drugs used in preterm labor.
- To summarize their mechanisms of action and clinical utility.
- To update providers on the latest evidence regarding tocolytic therapy.
Main Methods:
- Literature review of acute tocolytic medications.
- Analysis of clinical data on drug efficacy and safety.
- Comparison of commonly used tocolytic agents.
Main Results:
- Magnesium sulfate is the most frequently used tocolytic in the US.
- Oral nifedipine demonstrates comparable efficacy to magnesium sulfate but with fewer maternal side effects.
- Oral nifedipine is suggested as a first-line treatment option.
Conclusions:
- Tocolytic medications carry potential risks, including life-threatening side effects.
- Treatment decisions require careful consideration of preterm labor diagnosis, gestational age, patient comorbidities, and cost.
- Further research is needed to evaluate safety, side-effect profiles, and cost-effectiveness alongside efficacy.
Purpose Of Review:
The preterm birth rate in the United States remains at an all-time high and continues to rise. Acute tocolysis has potential to delay preterm birth for 48 h, the critical period of antenatal steroid administration, or to arrest an episode of preterm labor, thus delaying birth and improving neonatal outcomes. It is therefore paramount that medical providers remain up-to-date regarding the usefulness, indications and contraindications, and side-effects and adverse effects of all tocolytics.
Recent Findings:
Magnesium sulfate remains the most common tocolyic agent in the United States. Recent evidence comparing oral nifedipine with magnesium sulfate suggests equal efficacy with fewer maternal side-effects, thus supporting this oral medication as first-line treatment. This review will summarize the most common acute tocolytic drugs, their methods of action, and clinical data regarding their utility.
Summary:
All tocolytic medications have side-effects, some of them potentially life-threatening. Decisions regarding whether to use a tocolytic and which tocolytic to use require the diagnosis of preterm labor, knowledge of the patient's gestational age, medical conditions, and cost. Once tocolysis is initiated, attention must be paid to the patient's response, side-effects, and adverse events. Larger studies are needed which incorporate, in addition to efficacy, data on safety and side-effect profiles and cost.
